NCT02266264View on ClinicalTrials.gov

Hyperglycemia and Effects of Daily 100 mg Versus 200 mg of Hydrocortisone Therapy in Patients With Septic Shock

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Hyperglycemia
Interventions
DRUG

Hydrocortisone

Subjects will be divided into two groups by randomization. The intervention-group will be received 100 milligrams per day of hydrocortisone and the control-group will be received 200 milligrams per day of hydrocortisone in the first three days after enrollment.

Trial Locations (1)

26120

Department of Medicine, Faculty of Medicine, Srinakharinwirot University, Ongkharak

All Listed Sponsors
lead

Srinakharinwirot University

OTHER

NCT02266264 - Hyperglycemia and Effects of Daily 100 mg Versus 200 mg of Hydrocortisone Therapy in Patients With Septic Shock | Biotech Hunter | Biotech Hunter